Rockwell Medical (NASDAQ:RMTI) Lowered to “Hold” Rating by StockNews.com

StockNews.com downgraded shares of Rockwell Medical (NASDAQ:RMTI) from a buy rating to a hold rating in a report released on Thursday morning.

Other equities analysts have also recently issued research reports about the stock. Rodman & Renshaw started coverage on shares of Rockwell Medical in a research report on Thursday, November 14th. They set a “buy” rating and a $5.00 price objective on the stock. RODMAN&RENSHAW raised shares of Rockwell Medical to a “strong-buy” rating in a research report on Thursday, November 14th. Finally, HC Wainwright reissued a “buy” rating and set a $9.00 price objective on shares of Rockwell Medical in a research report on Wednesday, September 11th.

Rockwell Medical Price Performance

RMTI stock opened at $2.22 on Thursday. The stock has a market capitalization of $71.75 million, a PE ratio of -44.00 and a beta of 1.50. The company’s 50-day moving average is $3.56 and its 200-day moving average is $2.63. The company has a debt-to-equity ratio of 0.33, a current ratio of 2.41 and a quick ratio of 2.00. Rockwell Medical has a 1 year low of $1.16 and a 1 year high of $5.15.

Hedge Funds Weigh In On Rockwell Medical

Large investors have recently added to or reduced their stakes in the business. Vanguard Group Inc. lifted its position in Rockwell Medical by 4.0% in the 1st quarter. Vanguard Group Inc. now owns 1,118,277 shares of the company’s stock valued at $1,856,000 after acquiring an additional 43,302 shares in the last quarter. Armistice Capital LLC lifted its position in Rockwell Medical by 22.5% in the 2nd quarter. Armistice Capital LLC now owns 3,221,640 shares of the company’s stock valued at $5,670,000 after acquiring an additional 592,000 shares in the last quarter. Renaissance Technologies LLC lifted its position in Rockwell Medical by 877.1% in the 2nd quarter. Renaissance Technologies LLC now owns 102,700 shares of the company’s stock valued at $181,000 after acquiring an additional 92,189 shares in the last quarter. Beacon Financial Advisory LLC bought a new position in Rockwell Medical in the 3rd quarter valued at about $98,000. Finally, Verus Capital Partners LLC bought a new position in shares of Rockwell Medical during the 3rd quarter worth approximately $51,000. Institutional investors own 23.31% of the company’s stock.

About Rockwell Medical

Rockwell Medical, Inc, together with its subsidiaries, operates as a healthcare company that engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. The company offers Triferic Dialysate and Triferic AVNU which are indicated to maintain hemoglobin in adult undergoing hemodialysis.